Bitcoin has rebounded about 24% over two weeks but remains stuck between $76,000 and $82,000, trading near $77,000. CryptoQuant highlights that a decisive break above the 365-day moving average at $81,700 is needed to confirm a new bull market, as this level historically marks the start of sustained uptrends. Overhead supply and resistance zones, including long-term holders selling around $77,100–$80,200, must be absorbed before higher prices are realistic. Macro factors like inflation and Fed policy add uncertainty, while institutional views suggest the worst may be over but confirmation of a lasting uptrend is still pending.
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
